Skip to main content
. 2005 Mar;12(3):465–473. doi: 10.1128/CDLI.12.3.465-473.2005

FIG. 2.

FIG. 2.

Immunoreactivity of antigenic glycolipid characterized on a TLC plate with a serum sample from a patient confirmed to have an active case of TB with the BACTEC 460 system. Serum samples: A-1, immunoreactivity of antiglycolipid antibodies with serologically positive sera of patients with active pulmonary TB on a TLC plate; A-2, immunoreactivity of antiglycolipid antibodies with serologically positive sera of patients with extrapulmonary TB on a TLC plate; B-1, immunoreactivity of serologically significant antigens with sera from healthy BCG-vaccinated humans for cross-reactivity study on a TLC plate; B-2, immunoreactivity of serologically significant antigens with sera from BCG-unvaccinated healthy humans for cross-reactivity study on a TLC plate. Arrows indicate reactive bands.